72 related articles for article (PubMed ID: 23774400)
1. A short peptide derived from the gN helix domain of FGF8b suppresses the growth of human prostate cancer cells.
Li T; Luo W; He D; Wang R; Huang Y; Zeng X; Wang W; Chen X; Gao S; Yu Y; Li X; Wu X
Cancer Lett; 2013 Oct; 339(2):226-36. PubMed ID: 23774400
[TBL] [Abstract][Full Text] [Related]
2. A short peptide reverses the aggressive phenotype of prostate cancer cells.
Liu H; Lin X; Huang T; Song L; Zhu C; Ma H; Long T; Zeng H; Li R; Wang H; Huang Y; Chen L; Wu X
Eur J Pharmacol; 2018 Nov; 838():129-137. PubMed ID: 30196111
[TBL] [Abstract][Full Text] [Related]
3. Fibroblast growth factor 8 increases breast cancer cell growth by promoting cell cycle progression and by protecting against cell death.
Nilsson EM; Brokken LJ; Härkönen PL
Exp Cell Res; 2010 Mar; 316(5):800-12. PubMed ID: 19962979
[TBL] [Abstract][Full Text] [Related]
4. Identification of fibroblast growth factor-8b target genes associated with early and late cell cycle events in breast cancer cells.
Nilsson EM; Brokken LJ; Narvi E; Kallio MJ; Härkönen PL
Mol Cell Endocrinol; 2012 Jul; 358(1):104-15. PubMed ID: 22465097
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-8 signaling promotes translational regulation of cyclin D in androgen-independent prostate cancer cells.
MacManus CF; Pettigrew J; Seaton A; Wilson C; Maxwell PJ; Berlingeri S; Purcell C; McGurk M; Johnston PG; Waugh DJ
Mol Cancer Res; 2007 Jul; 5(7):737-48. PubMed ID: 17606477
[TBL] [Abstract][Full Text] [Related]
6. A neutralizing anti-fibroblast growth factor (FGF) 8 monoclonal antibody shows anti-tumor activity against FGF8b-expressing LNCaP xenografts in androgen-dependent and -independent conditions.
Maruyama-Takahashi K; Shimada N; Imada T; Maekawa-Tokuda Y; Ishii T; Ouchi J; Kusaka H; Miyaji H; Akinaga S; Tanaka A; Shitara K
Prostate; 2008 May; 68(6):640-50. PubMed ID: 18213631
[TBL] [Abstract][Full Text] [Related]
7. Screening a phage display library for a novel FGF8b-binding peptide with anti-tumor effect on prostate cancer.
Wang W; Chen X; Li T; Li Y; Wang R; He D; Luo W; Li X; Wu X
Exp Cell Res; 2013 May; 319(8):1156-64. PubMed ID: 23466786
[TBL] [Abstract][Full Text] [Related]
8. Effect of zinc on regulation of insulin-like growth factor signaling in human androgen-independent prostate cancer cells.
Banudevi S; Senthilkumar K; Sharmila G; Arunkumar R; Vijayababu MR; Arunakaran J
Clin Chim Acta; 2010 Feb; 411(3-4):172-8. PubMed ID: 19913001
[TBL] [Abstract][Full Text] [Related]
9. Functional interaction of fibroblast growth factor 8b and androgen in prostate cancer cell proliferation.
Xiao WJ; Zhang GM; Ye DW
Tumour Biol; 2017 Mar; 39(3):1010428317695969. PubMed ID: 28345462
[TBL] [Abstract][Full Text] [Related]
10. Dexamethasone suppresses DU145 cell proliferation and cell cycle through inhibition of the extracellular signal-regulated kinase 1/2 pathway and cyclin D1 expression.
Gao QZ; Lu JJ; Liu ZD; Zhang H; Wang SM; Xu H
Asian J Androl; 2008 Jul; 10(4):635-41. PubMed ID: 18097517
[TBL] [Abstract][Full Text] [Related]
11. Activation of the p38 MAPK/Akt/ERK1/2 signal pathways is required for the protein stabilization of CDC6 and cyclin D1 in low-dose arsenite-induced cell proliferation.
Liu Y; Hock JM; Sullivan C; Fang G; Cox AJ; Davis KT; Davis BH; Li X
J Cell Biochem; 2010 Dec; 111(6):1546-55. PubMed ID: 20862710
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.
Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ
Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705
[TBL] [Abstract][Full Text] [Related]
13. Gossypol inhibits the growth of MAT-LyLu prostate cancer cells by modulation of TGFbeta/Akt signaling.
Jiang J; Ye W; Lin YC
Int J Mol Med; 2009 Jul; 24(1):69-75. PubMed ID: 19513537
[TBL] [Abstract][Full Text] [Related]
14. Cyclin-dependent kinase inhibitor, P276-00, inhibits HIF-1α and induces G2/M arrest under hypoxia in prostate cancer cells.
Manohar SM; Padgaonkar AA; Jalota-Badhwar A; Rao SV; Joshi KS
Prostate Cancer Prostatic Dis; 2012 Mar; 15(1):15-27. PubMed ID: 22083267
[TBL] [Abstract][Full Text] [Related]
15. Formononetin induces cell cycle arrest of human breast cancer cells via IGF1/PI3K/Akt pathways in vitro and in vivo.
Chen J; Zeng J; Xin M; Huang W; Chen X
Horm Metab Res; 2011 Sep; 43(10):681-6. PubMed ID: 21932171
[TBL] [Abstract][Full Text] [Related]
16. Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells.
Chinni SR; Li Y; Upadhyay S; Koppolu PK; Sarkar FH
Oncogene; 2001 May; 20(23):2927-36. PubMed ID: 11420705
[TBL] [Abstract][Full Text] [Related]
17. Raloxifene induces cell death and inhibits proliferation through multiple signaling pathways in prostate cancer cells expressing different levels of estrogen receptor α and β.
Rossi V; Bellastella G; De Rosa C; Abbondanza C; Visconti D; Maione L; Chieffi P; Della Ragione F; Prezioso D; De Bellis A; Bellastella A; Sinisi AA
J Cell Physiol; 2011 May; 226(5):1334-9. PubMed ID: 20945400
[TBL] [Abstract][Full Text] [Related]
18. FGF-8b induces growth and rich vascularization in an orthotopic PC-3 model of prostate cancer.
Valta MP; Tuomela J; Vuorikoski H; Loponen N; Väänänen RM; Pettersson K; Väänänen HK; Härkönen PL
J Cell Biochem; 2009 Jul; 107(4):769-84. PubMed ID: 19415685
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide inhibits gastric cancer cell growth through the modulation of the Akt pathway.
Sang J; Chen Y; Tao Y
Mol Med Rep; 2011; 4(6):1163-7. PubMed ID: 21769431
[TBL] [Abstract][Full Text] [Related]
20. Identification of a novel aFGF-binding peptide with anti-tumor effect on breast cancer from phage display library.
Dai X; Cai C; Xiao F; Xiong Y; Huang Y; Zhang Q; Xiang Q; Lou G; Lian M; Su Z; Zheng Q
Biochem Biophys Res Commun; 2014 Mar; 445(4):795-801. PubMed ID: 24530908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
